Keywords: idm, expects, l-mtp-pe, ec, decision, 4th, qtr

IDM expects L-MTP-PE EC decision in 4th qtr

Article | 14 July 2008

Print This

US drugmaker IDM Pharma has requested additional data analyses from a Phase III trial of its osteosarcoma drug mifamurtide in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in